ChipCare Blog ChipCare Developing Integrated Microfluidic Platform for HIV Testing at Point of Care

By Leo O'Connor NEW YORK (GenomeWeb) - Toronto-based ChipCare is developing a microfluidic diagnostic platform that works similarly to a flow cytometer, but will be made available at a fraction of the cost and size. The firm, a 2009 spinout...The post ChipCare Developing Integrated Microfluidic Platform for HIV Testing at Point of Care appeared first on Chipcare Corporation.